Results 41 to 50 of about 381 (132)

Levodopa‐refractory hyperprolactinemia and pituitary findings in inherited disorders of biogenic amine metabolism

open access: yesJournal of Inherited Metabolic Disease, Volume 47, Issue 3, Page 431-446, May 2024.
Abstract Elevated serum prolactin concentrations occur in inherited disorders of biogenic amine metabolism because dopamine deficiency leads to insufficient inhibition of prolactin secretion. This work from the International Working Group on Neurotransmitter Related Disorders (iNTD) presents the results of the first standardized study on levodopa ...
Yılmaz Yıldız   +26 more
wiley   +1 more source

Clinical and radiological findings in macroprolactinemia [PDF]

open access: yes, 2012
Hyperprolactinemia is the most common abnormality of the hypothalamic-pituitary axis. The aim of this study was to investigate the clinical and radiological features of patients with macroprolactinemia.
TUTUNCU, Yasemin Ates   +9 more
core   +2 more sources

A macroprolactinemia--da determinação laboratorial ao seu significado clínico.

open access: yesActa Médica Portuguesa, 2011
Since prolactin (PRL) (a hormone produced by the anterior pituitary) was first identificated, the existence of hyperprolactinemic syndrome has been recognized.
Catarina Matos   +2 more
doaj   +1 more source

Macroprolactin over time: Is there any point in rechecking it in people with a persistently elevated serum prolactin?

open access: yesClinical Endocrinology, Volume 100, Issue 5, Page 450-458, May 2024.
Abstract Objective and Design Macroprolactinemia may influence the interpretation of serum prolactin levels—a recognised phenomenon since 1981. The degree of macroprolactinaemia over time is less well described. We determined how macroprolactin status (based on polyethylene glycol (PEG) precipitation) varied by analysing serial measurements in ...
Mark Livingston   +4 more
wiley   +1 more source

Assessment of macroprolactinemia inpatients with prolactinoma

open access: yes, 2017
Purpose:Macroprolactin, the high-molecular mass prolactin isoform, is considered to be an inactive product with extrapituitary origin. Although macroprolactinemia is considered a benign condition, there is evidence of overlapping clinical features among ...
Sema Ciftci Dogansen   +5 more
core   +1 more source

Macroprolactinemia among hyperprolactinemia patients in Hospital Universiti Sains Malaysia [PDF]

open access: yes, 2015
Background: HyperPRL is the most common hypothalamic-pituitary disorder encountered in clinical endocrinology. Macroprolactinemia is a known benign cause of hyperPRL.
Che Soh @ Yusof, Noor Azlin Azraini
core  

Serum Autoantibodies: From Identification to Clinical Relevance

open access: yes, 2013
Journal of Immunology Research, Volume 2013, Issue 1, 2013.
Pietro Invernizzi   +2 more
wiley   +1 more source

Macroprolactinemia Associated with Anti-Prolactin Antibodies: A Case Report

open access: yesEndocrinology Research and Practice, 2022
Macromolecular form of prolactin is generally associated with asymptomatic hyperprolactinemia. Increases in molecular size may result from self-aggregation or binding with antiprolactin antibodies.
Selçuk Dağdelen   +2 more
doaj   +2 more sources

Contemporary approaches to the diagnosis of hyperprolactinemia

open access: yesРепродуктивная эндокринология, 2019
Hyperprolactinemia (HP) is a persistent prolactin increase in serum. HP is a common endocrinopathy that impairs reproductive function, long term HP may lead to the metabolic disorders and a decrease in bone mineral density.
О. А. Бурка   +1 more
doaj   +1 more source

Macroprolactinaemiával társuló hypophysismacroadenoma kezelése quinagoliddal = Macroprolactinemia associated with pituitary macroadenoma: treatment with quinagolide [PDF]

open access: yes, 2010
A jelenlegi általános nézet szerint a makroprolaktin biológiailag inaktív molekula, ezért szérumkoncentrációjának növekedése aligha bír patológiai jelentőséggel.
Rácz, Károly   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy